6 Amendments of Patricija ŠULIN related to 2016/2164(DEC)
Amendment 3 #
Draft opinion
Paragraph 2 – point a (new)
Paragraph 2 – point a (new)
(a) Regrets the high level of carry- over of committed appropriations for administrative expenditure (26,6%); acknowledges that they mainly relate to an accelerated implementation of the multi-annual ICT strategy, arising from resources initially planned for salary increases but not needed following a decision by the Court of Justice of the European Union;
Amendment 4 #
Draft opinion
Paragraph 2 – point b (new)
Paragraph 2 – point b (new)
(b) Regrets that by the end of 2015 the Agency did not respect the ceiling of EUR 250 000 imposed in 2012 for its framework contract; regrets that by the end of 2015 the total payments made amounted to EUR 382 181, which means that the Agency exceeded that ceiling by 50 %; urges the Agency to improve its procedure for monitoring framework contracts;
Amendment 5 #
Draft opinion
Paragraph 3
Paragraph 3
3. Regrets that expenses on a given framework contract exceeded the estimate published by more than 50 %; welcomes, therefore, the cancellation of that contract and the launch of a new public procurement procedure; acknowledges the commitment of the Agency to improve the central planning and monitoring of its procurements; welcomes its overall performance with its limited budget;
Amendment 9 #
Draft opinion
Paragraph 4
Paragraph 4
4. Recognises that the Agency was successfulHighlights the success of the Agency in its different missions; welcomes the new strategy and work programme for 2016–2018; encourages, however, the development and implementation of a much longer-term strategy as committed by its Director;
Amendment 11 #
Draft opinion
Paragraph 5
Paragraph 5
5. Emphasises the important role of the Agency in detecting new trends and, assessing threats and developing prevention strategies posed by drugs to the health and security of young Europeans; welcomes the notification 98 new psychoactive substances (NPS); encourages sustained efforts to monitor the use of the internet as a vehicle for drug supply;
Amendment 16 #
Draft opinion
Paragraph 7 – point 1 (new)
Paragraph 7 – point 1 (new)
(1) Urges the Agency to publish all the declarations of interests and CVs of its executive, administrative and scientific directors as well as its experts; urges the Agency to ensure the independent verification of all "declarations of interests"; reiterates that transparency is key to alleviating the risks of conflicts of interest; calls upon the Agency to establish clear rules regarding the protection of whistle-blowers and "revolving doors";